FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT New Requirements for Info on ClinicalTrials.gov [258 Words]
11/19/2014
 
 
TXT FDA, EMA Advance ‘Mutual Reliance’ on GMP Inspections [209 Words]
11/20/2014
 
 
TXT Hamburg Signs Agreement with China on Inspection Collaboration [254 Words]
11/21/2014
 
 
TXT Alternative Approach to Drug Name Reservation Proposed [415 Words]
11/20/2014
 
 
TXT Developing a New Drug Costs $2.6 Billion: Tufts [439 Words]
11/18/2014
 
 
TXT Device Makers Need More Cybersecurity Input from FDA: Consultant [344 Words]
11/21/2014
 
 
TXT High-powered Lawyers Fighting LDT Proposal [322 Words]
11/18/2014
 
 
TXT House Appropriations Retains Aderholt to Handle FDA Budget [158 Words]
11/21/2014
 
 
TXT Court Denies Ranbaxy Generic Competition Block Bid [260 Words]
11/20/2014
 
 
TXT Look at Underlying Trends in Generic Drug Prices: Gottlieb [624 Words]
11/20/2014
 
 
TXT OIG Lists FDA Drug Safety Tasks [262 Words]
11/18/2014
 
 
TXT Latest Federal Register Notices [1306 Words]
11/23/2014
 
 
TXT Product Approval Summaries [533 Words]
11/23/2014
 
 
TXT Since Our Last Issue ... [425 Words]
11/23/2014
 
 
TXT 3 Guidances for Drug Compounding Outsourcing Facilities [1346 Words]
11/21/2014
 
 
TXT Allow Links to Risk Info in Social Media Promos, Groups Argue [358 Words]
11/21/2014
 
 
TXT Consent Decree Entered Against Dietary Supplement Maker [207 Words]
11/20/2014
 
 
TXT FDA Data Submission Issues Listed [211 Words]
11/20/2014
 
 
TXT Stericycle Sees Medical Device Recall Challenges [430 Words]
11/20/2014
 
 
TXT CDRH Extends UDI Labeling Compliance Date [351 Words]
11/20/2014
 
 
TXT ‘Failure to Warn’ Decision May be Meaningless: Blog [381 Words]
11/19/2014
 
 
TXT Justice Dept. Indicts Vascular Solutions on Unapproved Device [247 Words]
11/19/2014
 
 
TXT Mallinckrodt Asks Court to Nix FDA Action on Generic Concerta [421 Words]
11/19/2014
 
 
TXT FDA Seeks Drug Risk/Benefit Perception Measures [194 Words]
11/19/2014
 
 
TXT Gilead Buys Priority Review Voucher for $125 Million [111 Words]
11/19/2014
 
 
TXT Chemistry Question-based Review MAPP [290 Words]
11/19/2014
 
 
TXT Look at FDA Role in Drug Competition: Report [310 Words]
11/19/2014
 
 
TXT Latest FDA Warning Letters [585 Words]
11/18/2014
 
 
TXT FDA Revises Guidance on 505(q) Citizen Petitions [227 Words]
11/18/2014
 
 
TXT Wells Pharmacy Network Warned About Multiple Violations [476 Words]
11/18/2014
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving